During HCC progression, hepatic macrophages release pro-angiogenic factors such as transforming growth factor-β (TGF-β), vascular endothelial growth factor (VEGF), and platelet-derived growth factor (PDGF), which collectively promote tumor growth (99, 100). This evidence concerns the gene VEGFA and hepatocellular carcinoma.